Improving Early Recognition of Interstitial Lung Disease and the Management of Idiopathic Pulmonary Fibrosis
An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are commonly mischaracterized, and a correct diagnosis is often delayed. Additionally, treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis (IPF), hold promise for improved care and patient outcomes. These activities will examine strategies for identifying and accurately diagnosing ILD, as well as considerations for tailored management.Target audience:
Pulmonologists, radiologists, pathologists, primary care and other health care providers who encounter patients with ILD.
Mary E. Strek, MD
Kevin R. Flaherty, MD, MS